SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Investors of Class Action Involving GW Pharmaceuticals plc and a Le...
February 17 2016 - 10:21AM
The Law Offices of Vincent Wong announce that a class action
lawsuit has been commenced in the USDC for the Southern District of
New York on behalf of investors who purchased GW Pharmaceuticals
plc (Nasdaq:GWPH) securities between December 4, 2014 and January
8, 2016.
Click here to learn about the case:
http://docs.wongesq.com/GWPH-Info-Request-Form-1080.
There is no cost or obligation to you.
The complaint alleges that throughout the Class
Period, defendants made false and/or misleading statements and/or
failed to disclose that: (i) the Company lacked effective internal
financial controls; (ii) the Company lacked effective controls over
completeness and valuation of clinical trial accruals; and (iii) as
a result of the foregoing, Defendants’ statements about GW
Pharmaceuticals’ business, operations, and prospects were false and
misleading and/or lacked a reasonable basis.
In its 2015 Annual Report, GW Pharmaceuticals
disclosed the discovery of a material weakness in its internal
control over financial reporting for the year ended September 30,
2015. The Company noted that “management does not have sufficiently
precise controls to evaluate the completeness and accuracy of the
calculation of clinical trial accruals due to the incorrect
allocation of expenditure to clinical studies.” On this news, GW
Pharmaceuticals stock fell $3.55, or nearly 6%, to close at $56.31
per share on January 11, 2016.
If you suffered a loss in GW
Pharmaceuticals you have until March 21, 2016 to request
that the Court appoint you as lead plaintiff. Your ability to share
in any recovery doesn’t require that you serve as a lead plaintiff.
To obtain additional information, contact Vincent Wong, Esq. either
via email vw@wongesq.com, by telephone at 212.425.1140, or visit
http://docs.wongesq.com/GWPH-Info-Request-Form-1080.
Vincent Wong, Esq. is an experienced attorney
that has represented investors in securities litigation involving
financial fraud and violations of shareholder rights.
Attorney advertising. Prior results do not guarantee similar
outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com
GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From Jun 2024 to Jul 2024
GW Pharmaceuticals (NASDAQ:GWPH)
Historical Stock Chart
From Jul 2023 to Jul 2024